AI Verdict
KURA has stronger fundamentals based on our AI analysis.
KUST vs KURA Fundamental Comparison
| Metric | KUST | KURA |
|---|---|---|
| Revenue | $14.6M | $67.5M |
| Net Income | $-1.3M | $-278.7M |
| Net Margin | -8.9% | -412.9% |
| ROE | -17.3% | -160.0% |
| ROA | -5.2% | -37.7% |
| Current Ratio | 0.99x | 6.06x |
| Debt/Equity | 0.13x | 0.06x |
| EPS | $-1.40 | $-3.18 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KUST vs KURA: Frequently Asked Questions
Is KUST or KURA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KURA has stronger fundamentals. KUST is rated STRONG SELL (95% confidence) while KURA is rated HOLD (72% confidence). This is not investment advice.
How does KUST compare to KURA fundamentally?
KUSTOM ENTERTAINMENT, INC. has ROE of -17.3% vs Kura Oncology, Inc.'s -160.0%. Net margins are -8.9% vs -412.9% respectively.
Which stock pays higher dividends, KUST or KURA?
KUST has a dividend yield of N/A or no dividend while KURA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KUST or KURA for long term?
For long-term investing, consider that KUST has STRONG SELL rating with 95% confidence, while KURA has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KUST vs KURA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KUST vs KURA, the AI consensus favors KURA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.